GEODE CAPITAL MANAGEMENT, LLC - ZENTALIS PHARMACEUTICALS INC ownership

ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 117 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of ZENTALIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$23,810,896
-20.9%
1,186,837
+11.2%
0.00%
-25.0%
Q2 2023$30,117,033
+95.4%
1,067,601
+19.2%
0.00%
+100.0%
Q1 2023$15,409,916
+89160.4%
895,925
+4.5%
0.00%0.0%
Q4 2022$17,264
-99.9%
857,217
+2.5%
0.00%
-33.3%
Q3 2022$18,112,000
-17.5%
836,210
+7.0%
0.00%0.0%
Q2 2022$21,958,000
-28.6%
781,444
+17.3%
0.00%
-25.0%
Q1 2022$30,732,000
-44.7%
666,064
+0.7%
0.00%
-42.9%
Q4 2021$55,581,000
+29.8%
661,211
+2.9%
0.01%
+16.7%
Q3 2021$42,826,000
+81.4%
642,654
+44.8%
0.01%
+100.0%
Q2 2021$23,608,000
+48.3%
443,765
+21.0%
0.00%
+50.0%
Q1 2021$15,917,000
-7.6%
366,840
+10.6%
0.00%
-33.3%
Q4 2020$17,233,000
+190.6%
331,789
+82.9%
0.00%
+200.0%
Q3 2020$5,931,000
-23.9%
181,447
+11.8%
0.00%
-50.0%
Q2 2020$7,795,000162,3350.00%
Other shareholders
ZENTALIS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Paradigm Biocapital Advisors LP 300,434$25,254,0007.21%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 2,628,409$220,944,0006.56%
Avidity Partners Management LP 2,715,000$228,223,0004.84%
Matrix Capital Management Company, LP 4,349,279$365,600,0004.07%
Affinity Asset Advisors, LLC 117,500$9,877,0003.59%
Integral Health Asset Management, LLC 120,000$10,087,0002.79%
Ghost Tree Capital, LLC 80,000$6,725,0002.41%
Ikarian Capital, LLC 191,140$16,067,0002.39%
Tri Locum Partners LP 23,632$1,987,0000.78%
Eventide Asset Management 529,000$44,468,0000.57%
View complete list of ZENTALIS PHARMACEUTICALS INC shareholders